Keywords: spherix, reports, naturlose, ph, iii, results, usa-based

Spherix reports Naturlose Ph III results

Article | 19 May 2008

Print This

USA-based Spherix Inc has announced results from an ongoing Phase III clinical trial for its natural diabetes treatment Naturlose.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in